SPRY2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09278
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of human SPRY2 (NP_005833). Peptide sequence MEARAQSGNGSQPLLQTPRDGGRQRGEPDPRDALTQQVHVLSLDQIRAIR
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
35 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for SPRY2 Antibody
Immunohistochemistry-Paraffin: SPRY2 Antibody [NBP3-09278]
Immunohistochemistry-Paraffin: SPRY2 Antibody [NBP3-09278] - Immunohistochemical analysis of formalin-fixed paraffin-embedded human heart tissue.Applications for SPRY2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SPRY2
Long Name
Sprouty Homolog 2
Alternate Names
sprouty 2
Gene Symbol
SPRY2
Additional SPRY2 Products
Product Specific Notices for SPRY2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...